Navigation Links
Lilly and Glenmark Pharmaceuticals Announce License Agreement
Date:10/30/2007

Lilly to Acquire Next Generation Molecule GRC 6211 for the Potential

Treatment of Pain, Including Osteoarthritic Pain

INDIANAPOLIS and MUMBAI, India, Oct. 30 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that it has entered into an agreement with Glenmark Pharmaceuticals S.A. (GPSA) a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL). Under the terms of the agreement, Lilly will acquire the rights to a portfolio of transient receptor potential vanilloid sub-family 1 (TRPV1) antagonist molecules, including a clinical compound, GRC 6211. GRC 6211 is currently in early clinical Phase II development as a potential next-generation treatment for various pain conditions, including osteoarthritic pain.

Under the terms of the agreement, Glenmark will receive an upfront fee of $45 million and could receive up to an additional $215 million in potential development and sales milestones for the initial indication, as well as royalties on sales if GRC 6211 is successfully commercialized. If other indications are successfully developed, Glenmark would be entitled to additional milestones up to $90 million. Lilly will have marketing rights for North America, Europe and Japan, while Glenmark will retain the marketing rights in all other countries. Further Glenmark will have the right to co- promote GRC 6211 in the United States. Other terms of the deal were not disclosed.

"This agreement is further evidence of Lilly's commitment to seek out novel treatments for important medical conditions, such as osteoarthritic pain," commented William Chin, M.D., Lilly vice president, discovery research and clinical investigation. "We believe that TRPV1 represents
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
2. Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... that they have entered into a clinical trial collaboration ... investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with ... cancer medicine. The planned study will assess the combination ... The Phase I study is expected to ...
(Date:5/29/2015)... -- World-renowned prostate surgeon and New York Urologist, Dr. David ... MR/Ultrasound Fusion-Guided Biopsy for detecting aggressive prostate cancer ... at Lenox Hill Hospital is the only center using the ... York City . We,ve seen tremendous improvement in detecting ... of an MRI makes for a much more accurate diagnosis, ...
(Date:5/28/2015)... , May 28, 2015  Eli Lilly and Company ... its previously announced cash tender offer for up to $1.6 ... securities. Holders of notes who tendered, and did ... New York City time, on May ... for purchase by Lilly, are eligible to receive the total ...
Breaking Medicine Technology:Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 2Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 3Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 4Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 5Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 6Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 7Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 8Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 9Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 10Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 11Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 12Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 13Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors 14MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5
...  Watson Pharmaceuticals, Inc. (NYSE: WPI ), a ... Olafsson, Watson,s President of Global Generics, will provide an ... Jefferies 2012 Global Healthcare Conference on Monday, June 4, ... in New York, New York.  The presentation will be ...
... May 25, 2012  Marken announced today that it has ... will manage customer service operations and offer local service ... Korea.  Marken currently operates in the country through its ... out of the country.  This new office has been ...
Cached Medicine Technology:Watson to Present at the Jefferies 2012 Global Healthcare Conference 2Marken Opens Branch Office In Seoul, South Korea 2
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with ... of hanging signs ; making what was formerly an ... from ceiling rigging points at a usual height of 16’-20’ ... These signs are very unique and more visible than ... installation and dismantle labor and rigging the costs far outweigh ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Ready to hit ... important for all drivers to get their vehicles ready. With ... be prepared. Advanced Driving Systems (ADS) is ready to help ... on preparing for summer road trips. , When planning for ... following to ensure that the trip goes smoothly and they ...
(Date:5/29/2015)... PA (PRWEB) May 29, 2015 M3 ... quiz-based learning in 14 medical specialties, now offers ... a wide spectrum of rheumatology disorders ranging from Fibromyalgia ... Saint Jacques, editorial director of MDLinx, and Caroline Tredway, ... about the impact it will have on the physicians ...
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
(Date:5/29/2015)... Dot Hill can mark one more item off her bucket list: ... retirement community is the oldest woman to have flown at ... great fun!”, she exclaimed. “I’ve always wanted to jump from ... thought this would be ok.” , “We put on nylon coveralls, ... described. “I don’t remember it being noisy, but the wind ...
Breaking Medicine News(10 mins):Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Indoor Skydiving Brings Thrills to Seniors 2
... course of corticosteroids to patients after they get discharged from ... relapse. ,Giving the steroids also reduces their ... weeks. ,The study was conducted by a team ... part of the Cochrane Systematic Review. ,As part ...
... Former Palestinian President Yasser Arafat died of AIDS, a rival ... ,Ahmad Jibril, the founder of the Popular Front for the ... Daily News as saying that he received confirmation of this ... ,Jibril said that earlier he had suspected that Israel ...
... is gradually diminishing, and to solve the crisis the sector ... next five years, says an industry body . ,India's ... would require about 2.2 million beds and the investment needed ... Chambers of Commerce and Industry (FICCI) said in a presentation ...
... medicine manufacturing unit was busted in Orissa's Bolangir district and ... Saturday. ,A police team raided a factory ... from here, late Friday and seized the fake drugs, district ... IANS. ,Agarwal confessed that he supplied the fake ...
... four percent of American youths online have been asked to ... ,Researchers at the University of New Hampshire's ... 25 youth who use the Internet got a request to ... of the year. ,This study, published in the ...
... AMA is encouraging young people to feel more comfortable and ... President, Dr Rosanna Capolingua, said today that young people should ... on trust and confidentiality. ,There is a ... young people. They need to know that their GP is ...
Cached Medicine News:Health News:India Requires Over $200 Bn to Provide Quality Healthcare 2Health News:Four Percent of American Youths are Requested to Post Sexual Snaps on Web 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: